keto vs glp 1 Beyond GLP-1 Agonists: An Adaptive Ketogenic–Mediterranean Protocol to Counter Metabolic Adaptation in Obesity Management Comparing GLP‑1 Drugs With Other

Disqualifying conditions include Diabetes, Kidney Disease, Gallbladder Disease, Pancreatitis, Medullary Thyroid Carcinoma, Multiple Endocrine Neoplasia Syndrome Type 2, Thyroid Nodule that has not been evaluated, Pregnant or Breastfeeding Medical studies report patients losing 15-20% of their body weight on average after one year

doi:10.12688/f1000research.14817.1 19

Especially under ischemiareperfusion conditions, reducing the level of acylcarnitine has a significant effect on the energy metabolism of the heart and the maturity and proliferation of cardiomyocytes because reducing the utilization of fatty acids and increasing the reliance on glucose oxidation as an energy source can promote the recovery of myocardial function at a lower rate of oxygen consumption

Hsa_circ_0054633 mediates apoptosis and insulin secretion in human pancreatic cells through miR-409-3p/caspase-8 axis